Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 23 | 2025 | 449 | 9.280 |
Why?
|
| Alzheimer Disease | 16 | 2025 | 800 | 4.660 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 106 | 4.410 |
Why?
|
| Cognition | 24 | 2024 | 641 | 3.500 |
Why?
|
| Aged | 52 | 2025 | 4000 | 3.140 |
Why?
|
| Cognition Disorders | 14 | 2018 | 437 | 3.060 |
Why?
|
| Female | 59 | 2025 | 6974 | 2.650 |
Why?
|
| Male | 53 | 2025 | 6815 | 2.500 |
Why?
|
| Chicago | 23 | 2025 | 453 | 2.450 |
Why?
|
| tau Proteins | 5 | 2025 | 88 | 2.270 |
Why?
|
| Aged, 80 and over | 30 | 2025 | 2152 | 2.260 |
Why?
|
| Humans | 65 | 2025 | 12240 | 2.160 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 12 | 1.960 |
Why?
|
| Longitudinal Studies | 18 | 2025 | 651 | 1.750 |
Why?
|
| Aging | 9 | 2025 | 680 | 1.680 |
Why?
|
| Neurodegenerative Diseases | 2 | 2025 | 60 | 1.640 |
Why?
|
| Risk Factors | 17 | 2025 | 1049 | 1.610 |
Why?
|
| Cohort Studies | 16 | 2025 | 827 | 1.500 |
Why?
|
| Alleles | 6 | 2024 | 119 | 1.350 |
Why?
|
| Activities of Daily Living | 8 | 2018 | 182 | 1.340 |
Why?
|
| Stroke | 4 | 2016 | 117 | 1.330 |
Why?
|
| Prospective Studies | 13 | 2025 | 817 | 1.260 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 166 | 1.210 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 30 | 1.080 |
Why?
|
| Loneliness | 2 | 2025 | 31 | 1.040 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2024 | 12 | 1.030 |
Why?
|
| Diet, Mediterranean | 2 | 2024 | 27 | 1.010 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 100 | 1.010 |
Why?
|
| Blood Pressure | 2 | 2024 | 99 | 1.000 |
Why?
|
| Memory Disorders | 2 | 2024 | 68 | 0.950 |
Why?
|
| Mortality | 3 | 2018 | 37 | 0.930 |
Why?
|
| Biomarkers | 5 | 2025 | 294 | 0.930 |
Why?
|
| Lipids | 1 | 2025 | 28 | 0.870 |
Why?
|
| Social Isolation | 1 | 2025 | 15 | 0.870 |
Why?
|
| Incidence | 8 | 2025 | 338 | 0.840 |
Why?
|
| Dietary Fats | 1 | 2024 | 26 | 0.820 |
Why?
|
| Whole Grains | 1 | 2023 | 4 | 0.810 |
Why?
|
| Disability Evaluation | 3 | 2013 | 105 | 0.800 |
Why?
|
| Intermediate Filaments | 1 | 2022 | 5 | 0.710 |
Why?
|
| Exercise | 3 | 2022 | 233 | 0.690 |
Why?
|
| Depression | 2 | 2014 | 229 | 0.680 |
Why?
|
| Follow-Up Studies | 9 | 2024 | 726 | 0.670 |
Why?
|
| Geriatric Assessment | 4 | 2015 | 96 | 0.610 |
Why?
|
| United States | 8 | 2024 | 989 | 0.590 |
Why?
|
| Dementia | 5 | 2024 | 236 | 0.560 |
Why?
|
| Art | 1 | 2016 | 1 | 0.500 |
Why?
|
| Disease Progression | 6 | 2017 | 290 | 0.500 |
Why?
|
| Music | 1 | 2016 | 11 | 0.490 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 36 | 0.490 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 182 | 0.490 |
Why?
|
| Diabetes Complications | 1 | 2016 | 28 | 0.490 |
Why?
|
| Models, Statistical | 2 | 2021 | 60 | 0.480 |
Why?
|
| Neuropsychological Tests | 8 | 2018 | 558 | 0.460 |
Why?
|
| Mobility Limitation | 2 | 2015 | 36 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 82 | 0.450 |
Why?
|
| Genotype | 4 | 2024 | 169 | 0.450 |
Why?
|
| Body Mass Index | 5 | 2015 | 221 | 0.440 |
Why?
|
| Time Factors | 7 | 2017 | 695 | 0.430 |
Why?
|
| Independent Living | 3 | 2025 | 137 | 0.430 |
Why?
|
| Motor Activity | 2 | 2015 | 175 | 0.420 |
Why?
|
| Obesity | 3 | 2014 | 156 | 0.420 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 9 | 0.410 |
Why?
|
| Dopamine Agents | 1 | 2014 | 5 | 0.410 |
Why?
|
| Memantine | 1 | 2014 | 5 | 0.410 |
Why?
|
| Vitamin E | 1 | 2014 | 23 | 0.410 |
Why?
|
| Antioxidants | 1 | 2014 | 34 | 0.400 |
Why?
|
| Genome-Wide Association Study | 4 | 2022 | 108 | 0.390 |
Why?
|
| Memory, Episodic | 3 | 2018 | 43 | 0.380 |
Why?
|
| Health Status Disparities | 1 | 2013 | 30 | 0.380 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 110 | 0.380 |
Why?
|
| Diet | 2 | 2023 | 104 | 0.370 |
Why?
|
| Disabled Persons | 1 | 2012 | 47 | 0.350 |
Why?
|
| Linear Models | 3 | 2016 | 115 | 0.340 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.330 |
Why?
|
| Life Style | 2 | 2022 | 102 | 0.260 |
Why?
|
| Hypertension | 2 | 2024 | 85 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 98 | 0.230 |
Why?
|
| Healthy Lifestyle | 2 | 2024 | 24 | 0.230 |
Why?
|
| Triglycerides | 1 | 2025 | 24 | 0.220 |
Why?
|
| Cholesterol | 1 | 2025 | 30 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 14 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 10 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 13 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 13 | 0.220 |
Why?
|
| Risk Assessment | 2 | 2024 | 295 | 0.220 |
Why?
|
| Heterozygote | 1 | 2025 | 72 | 0.210 |
Why?
|
| Middle Aged | 11 | 2019 | 4043 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.190 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 6 | 0.190 |
Why?
|
| Age of Onset | 2 | 2013 | 46 | 0.190 |
Why?
|
| Life Expectancy | 1 | 2022 | 15 | 0.180 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 3 | 0.170 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 18 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 15 | 0.170 |
Why?
|
| Cost of Illness | 1 | 2021 | 24 | 0.170 |
Why?
|
| Prevalence | 1 | 2021 | 175 | 0.160 |
Why?
|
| Noise | 1 | 2020 | 11 | 0.160 |
Why?
|
| Cognitive Aging | 2 | 2018 | 34 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 464 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 87 | 0.160 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 38 | 0.160 |
Why?
|
| Phototherapy | 1 | 2019 | 17 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 153 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2016 | 66 | 0.140 |
Why?
|
| Genetic Loci | 2 | 2016 | 25 | 0.140 |
Why?
|
| Social Networking | 1 | 2018 | 7 | 0.140 |
Why?
|
| Healthy Aging | 1 | 2018 | 7 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 74 | 0.140 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 8 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 16 | 0.140 |
Why?
|
| Nursing Homes | 1 | 2018 | 27 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2019 | 69 | 0.140 |
Why?
|
| Social Environment | 1 | 2018 | 38 | 0.130 |
Why?
|
| Neuropathology | 1 | 2018 | 42 | 0.130 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 46 | 0.130 |
Why?
|
| Confidence Intervals | 1 | 2017 | 42 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 45 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 115 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.120 |
Why?
|
| Parity | 1 | 2016 | 1 | 0.120 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.120 |
Why?
|
| Reproduction | 1 | 2016 | 4 | 0.120 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 19 | 0.120 |
Why?
|
| Terrorism | 1 | 2016 | 7 | 0.120 |
Why?
|
| Warfare | 1 | 2016 | 9 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 20 | 0.120 |
Why?
|
| Reading | 1 | 2016 | 12 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 94 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 84 | 0.110 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 546 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 46 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2015 | 4 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 8 | 0.110 |
Why?
|
| Urinalysis | 1 | 2015 | 7 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 20 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 50 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 134 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 37 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 52 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 161 | 0.100 |
Why?
|
| Intelligence Tests | 1 | 2014 | 9 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 81 | 0.100 |
Why?
|
| Interview, Psychological | 1 | 2014 | 17 | 0.100 |
Why?
|
| Medicare | 1 | 2014 | 59 | 0.100 |
Why?
|
| Overweight | 1 | 2014 | 35 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 156 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 132 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 2004 | 41 | 0.100 |
Why?
|
| Gait | 1 | 2015 | 195 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 78 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 23 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2013 | 112 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2013 | 36 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 48 | 0.090 |
Why?
|
| Hospitalization | 1 | 2013 | 158 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 19 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2010 | 19 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 105 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 53 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 90 | 0.080 |
Why?
|
| Postmenopause | 3 | 2004 | 26 | 0.080 |
Why?
|
| Algorithms | 1 | 2010 | 169 | 0.080 |
Why?
|
| Adult | 4 | 2019 | 3557 | 0.070 |
Why?
|
| Testosterone | 2 | 2004 | 12 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 157 | 0.060 |
Why?
|
| Brain | 2 | 2024 | 707 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.050 |
Why?
|
| Copper | 1 | 2024 | 11 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2004 | 2 | 0.050 |
Why?
|
| Diet, Reducing | 1 | 2004 | 9 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 21 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2004 | 195 | 0.050 |
Why?
|
| Androgens | 1 | 2004 | 5 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 400 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 6 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 5 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 25 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 53 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 196 | 0.040 |
Why?
|
| Survivors | 2 | 2016 | 27 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 252 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 112 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 14 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 26 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 214 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 12 | 0.030 |
Why?
|
| Threonine | 1 | 2018 | 6 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 33 | 0.030 |
Why?
|
| Alanine | 1 | 2018 | 7 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2018 | 7 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2019 | 63 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 52 | 0.030 |
Why?
|
| Educational Status | 1 | 2018 | 130 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 229 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 155 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 350 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 256 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 122 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 5 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 12 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 8 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 3 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 5 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 7 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 7 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 23 | 0.030 |
Why?
|
| Neuroticism | 1 | 2016 | 13 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 193 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 14 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 16 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 16 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 47 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 2 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 12 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 10 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 20 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 15 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 48 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 110 | 0.030 |
Why?
|
| China | 1 | 2014 | 25 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 258 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 72 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 64 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 297 | 0.030 |
Why?
|
| Smoking | 1 | 2015 | 84 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 278 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 60 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 59 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 314 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2013 | 96 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 863 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 97 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 42 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 85 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 3 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 5 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 12 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 95 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 95 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 218 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 96 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 423 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 1467 | 0.020 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.010 |
Why?
|
| Body Size | 1 | 2004 | 3 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 46 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 9 | 0.010 |
Why?
|
| Washington | 1 | 2003 | 1 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 2 | 0.010 |
Why?
|
| Estrone | 1 | 2003 | 5 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 4 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2003 | 8 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 20 | 0.010 |
Why?
|
| Estradiol | 1 | 2003 | 26 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 62 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 281 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 168 | 0.010 |
Why?
|